[Mechanism of action of different inhibitors of thrombocyte aggregation].
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D001808:Blood Vessels / Q000187:drug effects / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D000242:Cyclic AMP / Q000097:blood; D003864:Depression, Chemical; D004336:Drug Antagonism; D004727:Endothelium / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D011464:Epoprostenol / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology; D011465:Prostaglandins, Synthetic / Q000494:pharmacology
D000975:Antioxidants; D002121:Calcium Channel Blockers; D004791:Enzyme Inhibitors; D011459:Prostaglandins E, Synthetic; D011465:Prostaglandins, Synthetic; D011464:Epoprostenol; D000242:Cyclic AMP
Mekhanizm deĭstviia razlichnykh ingibitorov agregatsii trombotsitov.